Chau Cheng

Investor Relations Kontakt bei IMMUNOVANT, INC.

Health Technology

Consumer Services

Aktive Positionen von Chau Cheng

Unternehmen	Position	Beginn	Ende
IMMUNOVANT, INC.	Investor Relations Kontakt	-	-

Unternehmen	Position	Beginn	Ende
CYTOMX THERAPEUTICS, INC.	Investor Relations Kontakt	01.12.2020	01.09.2022
CYTOMX THERAPEUTICS, INC.	Public Communications Contact	01.12.2020	01.09.2022
IMMUNOMEDICS, INC.	Investor Relations Kontakt	01.06.2004	01.12.2020
IMMUNOMEDICS, INC.	Unternehmenssekretär	01.06.2004	-

The Leonard N Stern School of Business

Masters Business Admin

International

Vereinigte Staaten

Operativ

Investor Relations Contact	3
Corporate Secretary	1
Public Communications Contact	1

Sektoral

Health Technology	4
Consumer Services	2

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	2
CYTOMX THERAPEUTICS, INC.	Health Technology
IMMUNOVANT, INC.	Health Technology

Private Unternehmen	1
Immunomedics, Inc. Immunomedics, Inc. BiotechnologyHealth Technology Immunomedics, Inc. researching, developing, manufacturing, and marketing biopharmaceutical products. It focuses on monoclonal antibody-based products for the targeted treatment of cancer. The company was founded by David M. Goldenberg in July 1982 and is headquartered in Morris Plains, NJ.	Health Technology